Hideki Iijima

8PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersPacific Peoples cultural determinants of healthHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 22, 2026
Serum leucine-rich α-2-glycoprotein and monocyte chemoattractant protein-1 as novel biomarkers for predicting vedolizumab response in patients with ulcerative colitis.

|Jul 11, 2025
Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study.

Takahiro Amano, Takeo Yoshihara, Tsutomu Nishida

|May 24, 2022
Lysophosphatidylserines derived from microbiota in Crohn's disease elicit pathological Th1 response.

Yuriko Otake-Kasamoto, Hisako Kayama, Toshihiro Kishikawa

|Apr 18, 2022
Exacerbation of non-steroidal anti-inflammatory drug-induced enteropathy in C-C chemokine receptor type 7-deficient mice.

Toshio Yamaguchi, Hideki Iijima, Takeo Yoshihara

|Jan 15, 2021
Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta-analysis.

Takeo Yoshihara, Shinichiro Shinzaki, Takahiro Amano

|May 20, 2020
Oligosaccharide-dependent anti-inflammatory role of galectin-1 for macrophages in ulcerative colitis.

Shuko Iwatani, Shinichiro Shinzaki, Takahiro Amano

Pageof 2

Frequent Collaborators

5 joint publications

Tetsuo Takehara

4 joint publications

Shinichiro Shinzaki

3 joint publications

Takeo Yoshihara

3 joint publications

Takahiro Amano